Journal of Medical Physics
 Home | Search | Ahead of print | Current Issue | Archives | Instructions | Subscription | Login  The official journal of Association of Medical Physicists of India      
 Users online: 311  Home  EMail this page Print this page Decrease font size Default font size Increase font size 
ORIGINAL ARTICLE
Year : 2008  |  Volume : 33  |  Issue : 1  |  Page : 14-18

Dosimetry and treatment planning of Occu-Prosta I-125 seeds for intraocular lesions


1 Department of Radiation Oncology, P. D. Hinduja National Hospital and MRC, Mumbai, India
2 Radiopharmaceutical Division, BARC, Mumbai, India
3 Radiological Physics and Advisory Division, BARC, Mumbai, India
4 Department of Ophthalmology, P. D. Hinduja National Hospital and MRC, Mumbai, India

Correspondence Address:
Sudesh Deshpande
Department of Radiation Oncology, P. D. Hinduja National Hospital and MRC, Veer Savarkar Marg, Mahim, Mumbai - 400 016
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-6203.39419

Rights and Permissions

Intraocular malignant lesions are frequently encountered in clinical practice. Plaque brachytherapy represents an effective means of treatment for intraocular lesions. Recently Radiopharmaceutical Division, BARC, Mumbai, has indigenously fabricated reasonable-cost I-125 sources. Here we are presenting the preliminary experience of dosimetry of sources, configuration of treatment planning system (TPS) and quality assurance (QA) for eye plaque therapy with Occu-Prosta I-125 seeds, treated in our hospital, for a patient with ocular lesions. I-125 seeds were calibrated using well-type chamber. BrachyVision TPS was configured with Monte Carlo computed radial dose functions and anisotropy functions for I-125 sources. Dose calculated by TPS at different points in central axis and off axis was compared with manually calculated dose. Eye plaque was fabricated of 17 karat pure gold, locally. The seeds were arranged in an outer ring near the edge of the plaque and in concentric rings throughout the plaque. The sources were manually digitized on the TPS, and dose distribution was calculated in three dimensions. Measured activity using cross-calibrated well-type chamber was within 10% of the activity specified by the supplier. Difference in TPS-calculated dose and manually calculated dose was within 5%. Treatment time calculated by TPS was in concordance with published data for similar plaque arrangement.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4257    
    Printed134    
    Emailed1    
    PDF Downloaded337    
    Comments [Add]    
    Cited by others 4    

Recommend this journal